Method and device for neural implant communication

Information

  • Patent Grant
  • 10918872
  • Patent Number
    10,918,872
  • Date Filed
    Tuesday, January 19, 2016
    9 years ago
  • Date Issued
    Tuesday, February 16, 2021
    4 years ago
Abstract
Communications along a neural pathway are provided. The neural pathway is stimulated at a first location, in order to evoke neural responses which propagate along the neural pathway, the neural responses being modulated with data. At a second location spaced apart from the first location along the neural pathway the evoked neural responses are sensed. The sensed neural responses are then demodulated to retrieve the data. The stimulation could comprise peripheral sensory stimulation, and the second location could be at an implanted electrode array.
Description
TECHNICAL FIELD

The present invention relates to implanted neural devices, being devices which are able to evoke and/or sense neural activity upon a neural pathway, and in particular to a method and system for establishing communication with such devices.


BACKGROUND OF THE INVENTION

A range of implanted neural devices exist, including: spinal cord implants which electrically stimulate the spinal column in order to suppress chronic pain; cochlear implants which electrically stimulate the auditory nerve to produce a hearing sensation; deep brain stimulators which electrically stimulate selected regions of the brain to treat conditions such as Parkinson's disease or epilepsy; and neural bypass devices which electrically stimulate either afferent sensory nerve fibres to reproduce impaired sensory function or efferent motor nerve fibres to reproduce impaired motor activity, or both.


With the advent of high capacity implantable batteries and power-efficient processing, implanted neural devices are becoming increasingly complex and in particular numerous aspects of operation of an implanted neural device may be reconfigurable. To control or reconfigure an implanted device thus requires the provision of a communications channel from a controller outside the body to the device within the body. Moreover, implanted neural devices are increasingly serving a data gathering role, and there exists a need to provide a communications channel from the device within the body to a data monitor outside the body.


Any discussion of documents, acts, materials, devices, articles or the like which has been included in the present specification is solely for the purpose of providing a context for the present invention. It is not to be taken as an admission that any or all of these matters form part of the prior art base or were common general knowledge in the field relevant to the present invention as it existed before the priority date of each claim of this application.


Throughout this specification the word “comprise”, or variations such as “comprises” or “comprising”, will be understood to imply the inclusion of a stated element, integer or step, or group of elements, integers or steps, but not the exclusion of any other element, integer or step, or group of elements, integers or steps.


In this specification, a statement that an element may be “at least one of” a list of options is to be understood that the element may be any one of the listed options, or may be any combination of two or more of the listed options.


SUMMARY OF THE INVENTION

According to a first aspect the present invention provides a method of communicating along a neural pathway, the method comprising:

    • stimulating the neural pathway at a first location, in order to evoke neural responses which propagate along the neural pathway, the neural responses being modulated with data;
    • sensing the evoked neural responses at a second location spaced apart from the first location along the neural pathway, and
    • demodulating the sensed neural responses to retrieve the data.


According to a second aspect the present invention provides a method of receiving a communication from a neural pathway; the method comprising:

    • sensing on the neural pathway a plurality of evoked neural responses; and
    • demodulating the sensed evoked responses to extract data.


According to a third aspect the present invention provides a method of transmitting information along a neural pathway, the method comprising:

    • evoking a plurality of neural responses on the neural pathway, the neural responses being modulated with data.


According to a fourth aspect the present invention provides an implantable device for communicating along a neural pathway, the device comprising:

    • sense electrodes and measurement circuitry for sensing neural responses passing along the neural pathway; and
    • a processor configured to demodulate sensed neural responses to extract data.


According to a fifth aspect the present invention provides a non-transitory computer readable medium for communicating along a neural pathway, comprising instructions which, when executed by one or more processors, causes performance of the following:

    • evoking a plurality of neural responses on the neural pathway, the neural responses being modulated with data.


The present invention thus utilises the neural pathway in a manner which is distinguishable from natural neural signals in order to enable an artificial function, being communication to and/or from an implanted neural device. That is, rather than detecting neural responses which are naturally arising, the present invention provides for the creation of artificially occurring neural responses which carry a data payload or are otherwise artificially modulated for the purpose of communication, but which need not have any intended meaningful sensory or motor purpose. The present invention thus utilises the neural pathway itself as a communications channel. In contrast to other communications techniques, such as wireless communications or bulk tissue conductance electrical propagation, which require considerable electrical power to establish the communications channel, the neural pathway does not need to be powered by the implanted device in order to function as a communications channel, as the action potential is a biological function requiring no electrical power input after the neural response is first evoked. That is, once evoked the action potential will continue to propagate for the full length of a healthy nerve without further external electrical power input.


The neural responses may be modulated with the data, such as being pulse width modulated, pulse amplitude modulated, pulse position modulated, amplitude or intensity modulated, delivered in bursts which are frequency modulated, modulated by analog or digital modulation, or they may be baseband on-off keying wherein presence of one or more neural responses within a given data bit window indicates a “1” and absence of a neural response within the window indicates a zero, or vice versa. The data is to be understood as being machine readable data, as distinct from neural signals having a biological function such as being intended for the brain. For example the data may be binary data.


In accordance with various embodiments of the invention, the implantable device may be configured to only receive data via the neural pathway, or to only transmit data via the neural pathway, or both. The implantable device may further be configured to communicate by other means, such as wireless transmission when desired.


In some embodiments of the invention, the neural responses evoked for the purposes of communication are configured to be comfortable for the implant recipient. Indeed in some embodiments the neural responses evoked for the purposes of communication may be configured to be minimally perceptible or wholly imperceptible by the implant recipient. Such embodiments recognise that certain low levels of neural activity are not perceived by the brain but can be selectively evoked by a suitable stimulator and detected by a suitable receiver. Such embodiments may therefore be advantageous in avoiding the implant recipient perceiving any, or any significant, aberrant effects from communications stimuli. The perceptibility of the evoked communications responses may additionally or alternatively be minimised by using very short-time stimuli for communications purposes and/or delivering stimuli in an interleaved manner with therapeutic stimuli so that the communications stimuli are not perceived or at least are not unpleasant to the user. It is to be noted that where neural responses are evoked by motor activity such as the implant recipient activating a muscle, or by sensory input such as the user touching their leg, the neural responses thereby evoked are perceptible but not typically uncomfortable and may nevertheless be modulated in order to effect communications along the neural pathway.


The step of stimulating the neural pathway may comprise stimulating the nerve directly, whether a spinal nerve, dorsal root ganglion or peripheral nerve. For example the nerve may be directly stimulated by an electrical stimulus, an infrared or optical stimulus or a chemical stimulus, in order to create neural responses modulated with data which travel to another site along the neural pathway for detection by a neural monitoring device.


Alternatively, the neural pathway may be indirectly evoked by delivering a peripheral sensory input, such as a somatic touch or temperature input, or by proprioceptive activity such as may be caused by the user activating or clenching one or more muscles or making one or more motions in a particular predetermined manner which gives rise to neural activity which can be interpreted by a device monitoring the neural pathway. Additionally or alternatively, the neural pathway may be indirectly evoked by delivering a visceral or parasympathetic sensory input in a particular predetermined manner which gives rise to neural activity which can be interpreted by a device monitoring an associated neural pathway.


In some embodiments the communications may originate from an external control device, and may be configured to control or alter the operation of an implanted device. For example the external control device may drive an input device such as a TENS device or a vibrational or haptic input device, to deliver encoded peripheral sensory stimuli which give rise to neural responses modulated with data which propagate along the afferent sensory nerves to the implanted device. Such embodiments may permit improved control of the duration, time and intensity of each stimulus, and thus may be particularly suited to delivery of higher data rates to the implanted device as compared to manual sensory input.


In some embodiments, the vibrational device used to deliver sensory input to the neural pathway may be the mechanical vibrator of a smartphone. Such embodiments may be particularly advantageous in utilising a device already owned by many implant recipients, and which has considerable computing power and thus may be programmed to provide advanced communications functionality with an implanted device by appropriately activating the mechanical vibrator for such communications purposes. The invention thus may be embodied in a smartphone app, which for example when executed controls a smartphone to communicate with an implant by vibrational sensory input.


Additionally or alternatively, in some embodiments the communications may originate from manual human sensory input, such as from the implant recipient. For example the communications originating from the implant recipient may be configured to control or alter the operation of an implanted device. In some such embodiments the implant recipient may manually deliver a sensory input to their peripheral nerves such as by tapping and/or stroking their leg(s) with their hand(s), in a predetermined pattern which gives rise to a pattern of neural responses which are detected and decoded by the implanted device. Additionally or alternatively, the communication may be initiated by motor input such as by the user clenching or activating one or more muscles or making one or more motions in a predetermined manner which gives rise to neural activity which can be detected and decoded by the implanted device monitoring the neural pathway. Initiating communications via motor activity rather than manual sensory input may be preferable if the implant recipient is self-conscious about delivering peripheral sensory inputs in public, as motor activity can be generated by activating muscles against resistance without requiring any movement and may thus be more discreet. While embodiments utilising manual sensory input are likely to achieve lower data rates than embodiments utilising an automated stimulus method, manual sensory input is nevertheless advantageous in permitting at least simple data input or device control to take place without the need for any external control device.


The encoding or modulation scheme used for manual sensory input communications is preferably configured to be distinguishable from normal motor activity, so that normal activity of the user is not undesirably detected as an instruction to change control settings of the implanted device. For example, motor or proprioceptive activity may be encoded by requiring consecutive motor actions or sensory inputs on one side of the body, so as to differentiate the encoded input from walking in which motor or proprioceptive activity occurs on alternating sides of the body. Formulating appropriate encoded sensory or motor input for a given implant recipient may be part of a fitting process after implantation of the implanted device. For example the user may have a preference of only tapping their feet to achieve such communications, or gently slapping their thighs, or the like. The user's preferred input activity may thus be accommodated during device fitting, in some embodiments. Moreover, the or each input pattern may resemble the rhythm of a favourite song or the like, to improve intuitiveness of the system for the user. In such embodiments the implanted device may thus be configured at the time of fitting to attach a unique control meaning to whichever input modulations are preferred by the user.


In further embodiments in which the communications originate from manual human input or a relocatable peripheral input such as a handheld TENS device, the implanted device may be configured to interpret such input as having occurred at a location at which paraesthesia is required. This may occur during a temporary re-mapping mode which may be entered when the implant recipient or a clinician wishes to redefine device parameters in order to change a region of paraesthesia delivered by the implanted device. When the device is in such a mode, an array of electrodes of the implanted device may detect neural responses on each electrode in a manner which corresponds to the indicated location of the required paraesthesia. The device may then reconfigure a stimulus pattern in a manner that optimises the stimuli delivered from each stimulus electrode, in a manner which optimally delivers paraesthesia to the location defined by the sensory input. Electrodes to sense the location being indicated by the manual sensory input may be positioned adjacent to one or more dorsal root ganglion in order to ease the location mapping to within the corresponding dermatome. A similar effect may be achieved by external device input such as by using an external haptic device to deliver sensory input at the location of required paraesthesia. Such embodiments may be particularly useful in cases of inaccurate electrode array implantation during surgery, or post-surgical lead migration, to facilitate re-mapping of stimulus electrodes.


Additionally or alternatively, in some embodiments the communications may originate from one implanted device which electrically stimulates neural responses, and the evoked responses may propagate in either an efferent or afferent direction along the neural pathway to a second implanted device, in order to effect communications between two implanted devices. A communications network between a plurality of implanted devices may thus be achieved. The communication network may comprise more than one neural pathway if data communicated along a first neural pathway is transferred to a second neural pathway by a suitable device or devices.


Additionally or alternatively, in some embodiments the communications may originate from an implanted device and may be configured to propagate to another location on the neural pathway to be detected and decoded by a device external to the body, such as cranial electrocardiography (ECG) electrodes configured to detect electrical neural activity or a surface electromyography (EMG) sensor configured to detect motor function such as a small muscle twitch or tic evoked by electrical stimulus of motor fibres by the implanted device, within the comfort range of the recipient, and modulated with data.


The communications delivered along the neural pathway may comprise instructions to activate or deactivate a radio or other communications component of the implanted device. Such embodiments thus permit the radio component to be deactivated when not required to permit a reduction in battery power consumption by the radio component, while also providing a means to reactivate the implanted radio, when required by a separate or external device or user.


The communications delivered along the neural pathway may comprise instructions to activate, deactivate or alter a therapeutic function of the implanted device. For example when the user of a spinal cord implant treating chronic pain intends to go to sleep they may instruct the device to turn off using communications in accordance with the present invention in order to save battery power overnight, and use equally simple inputs to reactivate the therapeutic function when they wake up.


The implanted device is preferably operable to differentiate between distally evoked neural activity and locally evoked neural activity, for example in the manner set forth in Australian Provisional Patent Application No. 2014904595, also by the present applicant. Such capability may be important in embodiments such as spinal cord implants where the implanted device's therapeutic function involves substantially continuous or ongoing locally evoked responses, from which distally evoked responses which carry a communications purpose for the device need to be differentiated.





BRIEF DESCRIPTION OF THE DRAWINGS

An example of the invention will now be described with reference to the accompanying drawings, in which:



FIG. 1 schematically illustrates an implanted spinal cord stimulator;



FIG. 2 is a block diagram of the implanted neurostimulator;



FIG. 3 is a schematic illustrating interaction of the implanted stimulator with a nerve;



FIG. 4 illustrates neural activity observed upon a neural pathway;



FIG. 5 illustrates modes of peripheral sensory data input to a neural device in accordance with one embodiment of the present invention;



FIG. 6 illustrates a mode of peripheral sensory input to a neural device in accordance with another embodiment of the present invention; and



FIG. 7 illustrates communication between two implanted neural devices along a neural pathway in accordance with another embodiment of the invention.





DESCRIPTION OF THE PREFERRED EMBODIMENTS


FIG. 1 schematically illustrates an implanted spinal cord stimulator 100. Stimulator 100 comprises an electronics module 110 implanted at a suitable location in the patient's lower abdominal area or posterior superior gluteal region, and an electrode assembly 150 implanted within the epidural space and connected to the module 110 by a suitable lead. Numerous aspects of operation of implanted neural device 100 are reconfigurable by an external control device 192. Moreover, implanted neural device 100 serves a data gathering role, and gathered data needs to be communicated to external device 192. These functions of implanted device 100 thus require the provision of a communications channel 190 from a controller 192 outside the body to the device 100 within the body.



FIG. 2 is a block diagram of the implanted neurostimulator 100. Module 110 contains a battery 112 and a telemetry module 114. In embodiments of the present invention, any suitable type of transcutaneous communication, such as infrared (IR), electromagnetic, capacitive and inductive transfer, may be used by telemetry module 114 to transfer power and/or data between an external device and the electronics module 110.


Module controller 116 has an associated memory 118 storing patient settings 120, control programs 122 and the like. Controller 116 controls a pulse generator 124 to generate stimuli in the form of current pulses in accordance with the patient settings 120 and control programs 122. Electrode selection module 126 switches the generated pulses to the appropriate electrode(s) of electrode array 150, for delivery of the current pulse to the tissue surrounding the selected electrode. Measurement circuitry 128 is configured to capture measurements of neural responses sensed at sense electrode(s) of the electrode array as selected by electrode selection module 126.



FIG. 3 is a schematic illustrating interaction of the implanted stimulator 100 with a nerve 180, in this case the spinal cord however alternative embodiments may be positioned adjacent any desired neural tissue including a peripheral nerve, visceral nerve, parasympathetic nerve or a brain structure. Electrode selection module 126 selects a stimulation electrode 2 of electrode array 150 to deliver an electrical current pulse to surrounding tissue including nerve 180, and also selects a return electrode 4 of the array 150 for stimulus current recovery to maintain a zero net charge transfer.


Delivery of an appropriate stimulus to the nerve 180 evokes a neural response comprising a compound action potential which will propagate along the nerve 180 as illustrated, for therapeutic purposes which in the case of spinal cord stimulator for chronic pain might be to create paraesthesia at a desired location.


The device 100 is further configured to sense the existence and intensity of compound action potentials (CAPs) propagating along nerve 180, whether such CAPs are evoked by the stimulus from electrodes 2 and 4, or otherwise evoked. Thus, communications originating elsewhere along the neural pathway and intended for the device 100, and comprising an encoded sequence of action potentials, may be sensed by the device 100. To this end, any electrodes of the array 150 may be selected by the electrode selection module 126 to serve as measurement electrode 6 and measurement reference electrode 8. Signals sensed by the measurement electrodes 6 and 8 are passed to measurement circuitry 128, which for example may operate in accordance with the teachings of International Patent Application Publication No. WO2012155183 by the present applicant, the content of which is incorporated herein by reference.



FIG. 4 is a plot of neural activity observed upon the spinal cord 180 by the device 100. During the period shown, four minutes, the implant recipient was asked to perform certain movements, as follows: no movement at around 20-30 s, rubbing leg around 40-50 s, lifting leg around 60-70 s, and walking during the period 120-140 s. The present invention recognises that each active movement is distinguishable from a lack of movement, and that each such sensory or proprioceptive input can be deliberately modulated with data in order to communicate with the neural device 100.



FIG. 5 illustrates modes of peripheral sensory data input involving the user tapping their feet and/or slapping their thighs. The user may know to perform such activities in a predefined pattern which can be distinguished in the neural signal as a communication, for example the user may tap their feet in Morse code or to replicate a favourite song. The user may also or alternatively clench or activate certain muscle(s) to communicate with the SCS 100.



FIG. 6 illustrates machine-assisted sensory input to communicate with the implanted device 100, in the form of a smartphone 600 configured to deliver vibrational sensory inputs to the user's thigh, to induce afferent sensory activity on the lateral femoral cutaneous nerve 602, for detection by the device 100. In this embodiment, communication of external information or commands to the implanted system 100 is effected by placing the vibration device 600 on an area of skin which is neurologically addressed by the electrode array 150. External information or commands are encoded as a sequence of vibrations, and the device 600 is controlled to vibrate according to that sequence. The evoked sequence of neural stimuli then propagate afferently along nerve 602 and into the spinal cord 180 and are then observed through the electrodes 150. The observed neural response sequence is decoded by the implant 110 to recover the original information or commands. The encoding of the sequence of vibrations may be carried out in accordance with any suitable encoding scheme such as being pulse width modulated, pulse amplitude modulated, pulse position modulated, amplitude or intensity modulated, delivered in bursts which are frequency modulated, modulated by analog or digital modulation, or on-off keying. This arrangement has the advantage that there is no need for the telemetry module 114 to be constantly active to receive radio communications. Instead, sensory input communications from device 600 may be used to selectively activate telemetry module 114 only when needed, or may be used for any other communications purpose.


Device 600 operates in this manner under the control of an app, and such apps configured for communications with neural implants for therapeutic or other purposes are within the scope of the present invention.


The arrangement of FIG. 6 may additionally or alternatively be used to re-program a site of paraesthesia effected by device 100. In such embodiments, the memory 118 is populated with a store of calibration data to assist in identifying the location where the skin is touched by device 600. The calibration data is produced as follows: (a) neural responses are measured by device 100 while touching specified locations on the skin, and (b) information is stored in the calibration store indicating the nature of measurements which arise for each location. Then when re-programming of the site of paraesthesia is required, as may be initiated by any suitable communications method including those described herein, a re-programming mode is entered in which the device 600 is held against the skin at a location of desired paraesthesia, and caused to deliver vibrational sensory inputs. The evoked neural activity is observed by device 100 and matched to the closest match(es) from the calibration store in memory 118, and used to re-set the patient settings 120 such as stimulus electrode selection.



FIG. 7 illustrates communication between two implanted devices 110 and 710, along a neural pathway 180. Device 710 is a vagus nerve stimulator which comprises an implanted electrode array 752 configured to stimulate the vagus nerve 182 for therapeutic purposes such as treatment of epilepsy or depression. Device 710 further comprises an electrode array 750 implanted alongside the spinal cord 180 in order to enable communications with the device 110 along the communications channel provided by the spinal cord 180. Device 110 may thereby communicate with device 710 by causing the delivery of encoded stimuli from electrode array 150 to the spinal cord 180, in order to evoke neural responses which propagate along the spinal cord. Array 750 is then able to sense the passing sequence of neural activity evoked by the device 110, from which the device 710 decodes the communications. For example, device 110 may be operable to monitor a heart rate of the patient by reference to heartbeat modulations of observed neural responses on the spinal cord 180, and to communicate to device 710 at times when changed vagus nerve stimulation is required in order to influence a heart rate of the patient. The configuration of array 750 and the associated components of device 710 may be substantially the same as for device 100 as shown in FIG. 3.


It will be appreciated by persons skilled in the art that numerous variations and/or modifications may be made to the invention as shown in the specific embodiments without departing from the spirit or scope of the invention as broadly described. The present embodiments are, therefore, to be considered in all respects as illustrative and not limiting or restrictive.

Claims
  • 1. A method of communicating along a neural pathway, the method comprising: stimulating the neural pathway at a first location, the first location being a peripheral location, in order to evoke neural responses which propagate along the neural pathway, the neural responses being modulated with machine readable binary data;sensing, using an implantable device, the evoked neural responses at a second location spaced apart from the first location along the neural pathway, anddemodulating, using the implantable device, the sensed neural responses to retrieve the machine readable binary data, the machine readable binary data being configured to control or alter the operation of the implanted device.
  • 2. The method of claim 1 wherein the neural responses are modulated with the machine readable binary data by on-off keying.
  • 3. The method of claim 1 wherein the machine readable binary data instructs the implantable device to activate a wireless transceiver.
  • 4. The method of claim 1 wherein the neural responses are minimally perceptible or imperceptible by an implant recipient.
  • 5. The method of claim 4 wherein stimulating the neural pathway at the first location comprises using short-time stimuli configured to evoke neural responses which are minimally perceptible or imperceptible.
  • 6. The method of claim 4 wherein perceptions of the evoked neural responses are minimised by delivering stimuli in an interleaved manner with therapeutic stimuli.
  • 7. The method of claim 1 wherein the modulated neural responses are evoked by motor activity.
  • 8. The method of claim 1 wherein the modulated neural responses are evoked by sensory input.
  • 9. The method of claim 1 wherein the modulated neural responses are evoked by stimulating the neural pathway directly.
  • 10. The method of claim 1 wherein stimulating the neural pathway at the first location is performed by an external control device.
  • 11. The method of claim 10 wherein the external control device comprises a vibrational input device.
  • 12. The method of claim 11 wherein the vibrational input device is a mechanical vibrator of a smartphone.
  • 13. The method of claim 12 wherein the fitting process includes configuring the implanted device to attach a unique control meaning to input modulations selected by an implant recipient.
  • 14. The method of claim 1, further comprising formulating appropriate encoded sensory or motor input for a given implant recipient as part of a fitting process after implantation of the implanted device.
  • 15. The method of claim 1 further comprising the implanted device entering a temporary re-mapping mode to redefine device parameters in order to change a region of paraesthesia delivered by the implantable device.
  • 16. The method of claim 1, wherein communications originate from one implanted device which electrically stimulates neural responses, and wherein the evoked responses propagate along the neural pathway to a second implanted device, in order to effect communications between two implanted devices.
  • 17. The method of claim 1 wherein the implanted device is operable to differentiate between distally evoked neural activity and locally evoked neural activity.
  • 18. A method of receiving a communication from a neural pathway; the method performed by an implantable device, and the method comprising: sensing on the neural pathway a plurality of evoked neural responses evoked at a peripheral location and carrying modulated machine readable binary data;demodulating the sensed evoked responses to extract the machine readable binary data; andprocessing the machine readable binary data to control or alter the operation of the implanted device.
  • 19. An implantable device for communicating along a neural pathway, the device comprising: sense electrodes and measurement circuitry for sensing neural responses passing along the neural pathway, the neural responses evoked at a peripheral location and carrying modulated machine readable binary data; anda processor configured to demodulate sensed neural responses to extract machine readable binary data, the processor further configured to process the machine readable binary data to control or alter the operation of the implanted device.
Priority Claims (1)
Number Date Country Kind
2015900134 Jan 2015 AU national
PCT Information
Filing Document Filing Date Country Kind
PCT/AU2016/050019 1/19/2016 WO 00
Publishing Document Publishing Date Country Kind
WO2016/115596 7/28/2016 WO A
US Referenced Citations (275)
Number Name Date Kind
3736434 Darrow May 1973 A
3817254 Maurer Jun 1974 A
3898472 Long Aug 1975 A
4158196 Crawford, Jr. Jun 1979 A
4418695 Buffet Dec 1983 A
4474186 Ledley et al. Oct 1984 A
4628934 Pohndorf et al. Dec 1986 A
4807643 Rosier Feb 1989 A
4856525 Van et al. Aug 1989 A
5113859 Funke May 1992 A
5139020 Koestner et al. Aug 1992 A
5143081 Young et al. Sep 1992 A
5156154 Valenta, Jr. et al. Oct 1992 A
5172690 Nappholz et al. Dec 1992 A
5184615 Nappholz et al. Feb 1993 A
5188106 Nappholz et al. Feb 1993 A
5215100 Spitz Jun 1993 A
5324311 Acken Jun 1994 A
5417719 Hull et al. May 1995 A
5431693 Schroeppel Jul 1995 A
5458623 Lu et al. Oct 1995 A
5476486 Lu et al. Dec 1995 A
5497781 Chen et al. Mar 1996 A
5638825 Yamazaki et al. Jun 1997 A
5702429 King et al. Dec 1997 A
5758651 Nygard et al. Jun 1998 A
5776170 Macdonald et al. Jul 1998 A
5785651 Kuhn et al. Jul 1998 A
5792212 Weijand et al. Aug 1998 A
5814092 King Sep 1998 A
5913882 King Jun 1999 A
5999848 Gord et al. Dec 1999 A
6020857 Podger Feb 2000 A
6027456 Feler et al. Feb 2000 A
6038480 Hrdlicka et al. Mar 2000 A
6066163 John May 2000 A
6114164 Dennis et al. Sep 2000 A
6144881 Hemming et al. Nov 2000 A
6157861 Faltys et al. Dec 2000 A
6212431 Hahn et al. Apr 2001 B1
6246912 Sluijter et al. Jun 2001 B1
6381496 Meadows et al. Apr 2002 B1
6449512 Boveja Sep 2002 B1
6463328 John Oct 2002 B1
6473649 Gryzwa et al. Oct 2002 B1
6473653 Schallhorn et al. Oct 2002 B1
6493576 Dankwart-Eder Dec 2002 B1
6522932 Kuzma Feb 2003 B1
6600955 Zierhofer et al. Jul 2003 B1
6658293 Vonk et al. Dec 2003 B2
6675046 Holsheimer Jan 2004 B2
6782292 Whitehurst Aug 2004 B2
6898582 Lange et al. May 2005 B2
7089059 Pless Aug 2006 B1
7171261 Litvak et al. Jan 2007 B1
7231254 DiLorenzo et al. Jun 2007 B2
7286876 Yonce et al. Oct 2007 B2
7412287 Yonce et al. Aug 2008 B2
7450992 Cameron Nov 2008 B1
7734340 De Jun 2010 B2
7742810 Moffitt Jun 2010 B2
7792584 Van et al. Sep 2010 B2
7818052 Litvak et al. Oct 2010 B2
7831305 Gliner Nov 2010 B2
7835804 Fridman et al. Nov 2010 B2
7894905 Pless et al. Feb 2011 B2
8190251 Molnar et al. May 2012 B2
8224459 Pianca et al. Jul 2012 B1
8239031 Fried et al. Aug 2012 B2
8359102 Thacker et al. Jan 2013 B2
8417342 Abell Apr 2013 B1
8494645 Spitzer et al. Jul 2013 B2
8588929 Davis et al. Nov 2013 B2
8670830 Carlson et al. Mar 2014 B2
8886323 Wu et al. Nov 2014 B2
9155892 Parker et al. Oct 2015 B2
9302112 Bornzin et al. Apr 2016 B2
9381356 Parker et al. Jul 2016 B2
9386934 Parker et al. Jul 2016 B2
9872990 Parker et al. Jan 2018 B2
9974455 Parker et al. May 2018 B2
10206596 Single et al. Feb 2019 B2
10278600 Parker et al. May 2019 B2
10426409 Single Oct 2019 B2
10500399 Single Dec 2019 B2
10568559 Parker et al. Feb 2020 B2
10588524 Single et al. Mar 2020 B2
10588698 Parker et al. Mar 2020 B2
10632307 Parker Apr 2020 B2
20020055688 Katims May 2002 A1
20020099419 Ayal et al. Jul 2002 A1
20020193670 Garfield et al. Dec 2002 A1
20030032889 Wells Feb 2003 A1
20030045909 Gross et al. Mar 2003 A1
20030139781 Bradley et al. Jul 2003 A1
20030153959 Thacker et al. Aug 2003 A1
20030195580 Bradley et al. Oct 2003 A1
20040088017 Sharma et al. May 2004 A1
20040122482 Tung et al. Jun 2004 A1
20040158298 Gliner Aug 2004 A1
20040225211 Gozani et al. Nov 2004 A1
20040254494 Spokoyny et al. Dec 2004 A1
20050010265 Baru Fassio Jan 2005 A1
20050017190 Eversmann et al. Jan 2005 A1
20050021104 DiLorenzo Jan 2005 A1
20050065427 Magill Mar 2005 A1
20050070982 Heruth et al. Mar 2005 A1
20050075683 Miesel et al. Apr 2005 A1
20050101878 Daly May 2005 A1
20050113877 Giardiello et al. May 2005 A1
20050137670 Christopherson et al. Jun 2005 A1
20050149154 Cohen Jul 2005 A1
20050192567 Katims Sep 2005 A1
20050203600 Wallace Sep 2005 A1
20050209655 Bradley et al. Sep 2005 A1
20050282149 Kovacs et al. Dec 2005 A1
20060009820 Royle et al. Jan 2006 A1
20060020291 Gozani Jan 2006 A1
20060135998 Libbus et al. Jun 2006 A1
20060195159 Bradley et al. Aug 2006 A1
20060212089 Tass Sep 2006 A1
20060217782 Boveja et al. Sep 2006 A1
20060264752 Rubinsky et al. Nov 2006 A1
20060287609 Litvak et al. Dec 2006 A1
20070021800 Bradley et al. Jan 2007 A1
20070073354 Knudson et al. Mar 2007 A1
20070100378 Maschino May 2007 A1
20070178579 Ross et al. Aug 2007 A1
20070185409 Wu et al. Aug 2007 A1
20070208394 King et al. Sep 2007 A1
20070225767 Daly et al. Sep 2007 A1
20070244410 Fridman et al. Oct 2007 A1
20070250120 Flach et al. Oct 2007 A1
20070255372 Metzler et al. Nov 2007 A1
20070282217 McGinnis et al. Dec 2007 A1
20070287931 Dilorenzo Dec 2007 A1
20080021292 Stypulkowski Jan 2008 A1
20080051647 Wu et al. Feb 2008 A1
20080064947 Heruth et al. Mar 2008 A1
20080077191 Morrell Mar 2008 A1
20080097529 Parramon et al. Apr 2008 A1
20080147155 Swoyer Jun 2008 A1
20080183076 Witte Jul 2008 A1
20080208304 Zdravkovic et al. Aug 2008 A1
20080234780 Smith et al. Sep 2008 A1
20080275527 Greenberg et al. Nov 2008 A1
20080294221 Kilgore Nov 2008 A1
20080300655 Cholette Dec 2008 A1
20080319508 Botros et al. Dec 2008 A1
20090033486 Costantino et al. Feb 2009 A1
20090058635 Lalonde et al. Mar 2009 A1
20090082691 Denison et al. Mar 2009 A1
20090149912 Dacey, Jr. et al. Jun 2009 A1
20090157155 Bradley Jun 2009 A1
20090270957 Pianca Oct 2009 A1
20090287277 Conn et al. Nov 2009 A1
20090299214 Wu et al. Dec 2009 A1
20090306491 Haggers Dec 2009 A1
20100010388 Panken et al. Jan 2010 A1
20100058126 Chang et al. Mar 2010 A1
20100069835 Parker Mar 2010 A1
20100069996 Strahl Mar 2010 A1
20100070007 Parker Mar 2010 A1
20100070008 Parker Mar 2010 A1
20100100153 Carlson et al. Apr 2010 A1
20100106231 Torgerson Apr 2010 A1
20100114237 Giftakis et al. May 2010 A1
20100114258 Donofrio et al. May 2010 A1
20100125313 Lee et al. May 2010 A1
20100125314 Bradley et al. May 2010 A1
20100145222 Brunnett et al. Jun 2010 A1
20100152808 Boggs Jun 2010 A1
20100179626 Pilarski Jul 2010 A1
20100191307 Fang et al. Jul 2010 A1
20100204748 Lozano et al. Aug 2010 A1
20100222844 Troosters et al. Sep 2010 A1
20100222858 Meloy Sep 2010 A1
20100249643 Gozani et al. Sep 2010 A1
20100249867 Wanasek Sep 2010 A1
20100258342 Parker Oct 2010 A1
20100262208 Parker Oct 2010 A1
20100262214 Robinson Oct 2010 A1
20100280570 Sturm et al. Nov 2010 A1
20100286748 Midani et al. Nov 2010 A1
20100331604 Okamoto et al. Dec 2010 A1
20100331926 Lee et al. Dec 2010 A1
20110004207 Wallace et al. Jan 2011 A1
20110021943 Lacour et al. Jan 2011 A1
20110028859 Chian Feb 2011 A1
20110040546 Gerber et al. Feb 2011 A1
20110087085 Tsampazis et al. Apr 2011 A1
20110093042 Torgerson et al. Apr 2011 A1
20110106100 Bischoff May 2011 A1
20110184488 De et al. Jul 2011 A1
20110204811 Pollmann-retsch Aug 2011 A1
20110224665 Crosby et al. Sep 2011 A1
20110224749 Ben-David et al. Sep 2011 A1
20110264165 Molnar et al. Oct 2011 A1
20110270343 Buschman et al. Nov 2011 A1
20110307030 John Dec 2011 A1
20110313310 Tomita Dec 2011 A1
20110313483 Hincapie et al. Dec 2011 A1
20120029377 Polak Feb 2012 A1
20120059275 Fagin et al. Mar 2012 A1
20120101552 Lazarewicz et al. Apr 2012 A1
20120109004 Cadwell May 2012 A1
20120109236 Jacobson et al. May 2012 A1
20120155183 Aritome Jun 2012 A1
20120185020 Simon et al. Jul 2012 A1
20120253423 Youn et al. Oct 2012 A1
20120277621 Gerber et al. Nov 2012 A1
20120277823 Gerber et al. Nov 2012 A1
20130053722 Carlson et al. Feb 2013 A1
20130060302 Polefko et al. Mar 2013 A1
20130172774 Crowder et al. Jul 2013 A1
20130289661 Griffith et al. Oct 2013 A1
20130289683 Parker et al. Oct 2013 A1
20140066803 Choi Mar 2014 A1
20140142447 Takahashi et al. May 2014 A1
20140194771 Parker et al. Jul 2014 A1
20140194772 Single et al. Jul 2014 A1
20140236042 Parker et al. Aug 2014 A1
20140236257 Parker et al. Aug 2014 A1
20140243926 Carcieri Aug 2014 A1
20140243931 Parker et al. Aug 2014 A1
20140249396 Shacham-diamand et al. Sep 2014 A1
20140276195 Papay et al. Sep 2014 A1
20140277250 Su et al. Sep 2014 A1
20140288551 Bharmi et al. Sep 2014 A1
20140288577 Robinson et al. Sep 2014 A1
20140296737 Parker et al. Oct 2014 A1
20140350634 Grill et al. Nov 2014 A1
20140358024 Nelson et al. Dec 2014 A1
20150018699 Zeng et al. Jan 2015 A1
20150164354 Parker et al. Jun 2015 A1
20150174396 Fisher et al. Jun 2015 A1
20150238104 Tass Aug 2015 A1
20150238304 Lamraoui Aug 2015 A1
20150282725 Single Oct 2015 A1
20150313487 Single Nov 2015 A1
20150360031 Bornzin et al. Dec 2015 A1
20150374999 Parker Dec 2015 A1
20160082265 Moffitt et al. Mar 2016 A1
20160082268 Hershey et al. Mar 2016 A1
20160106980 Sürth et al. Apr 2016 A1
20160121124 Johanek et al. May 2016 A1
20160129272 Hou et al. May 2016 A1
20160166164 Obradovic et al. Jun 2016 A1
20160175594 Min et al. Jun 2016 A1
20160287126 Parker et al. Oct 2016 A1
20160287182 Single Oct 2016 A1
20160367808 Simon et al. Dec 2016 A9
20170001017 Parker et al. Jan 2017 A9
20170049345 Single Feb 2017 A1
20170071490 Parker et al. Mar 2017 A1
20170135624 Parker May 2017 A1
20170216587 Parker Aug 2017 A1
20170361101 Single Dec 2017 A1
20180110987 Parker Apr 2018 A1
20180117335 Parker et al. May 2018 A1
20180132747 Parker et al. May 2018 A1
20180132760 Parker May 2018 A1
20180133459 Parker et al. May 2018 A1
20180228391 Parker et al. Aug 2018 A1
20180228547 Parker Aug 2018 A1
20180256052 Parker et al. Sep 2018 A1
20190168000 Laird-Wah Jun 2019 A1
20190239768 Karantonis et al. Aug 2019 A1
20190307341 Parker et al. Oct 2019 A1
20190357788 Single Nov 2019 A1
20200029914 Single Jan 2020 A1
20200129108 Parker et al. Apr 2020 A1
20200155240 Parker et al. May 2020 A1
20200215331 Single Jul 2020 A1
20200282208 Parker Sep 2020 A1
Foreign Referenced Citations (87)
Number Date Country
103648583 Mar 2014 CN
103654762 Mar 2014 CN
103842022 Jun 2014 CN
104411360 Mar 2015 CN
0219084 Apr 1987 EP
0998958 Aug 2005 EP
2019716 Nov 2007 EP
2243510 Oct 2010 EP
2443995 Apr 2012 EP
2707095 Mar 2014 EP
3229893 Oct 2017 EP
2006504494 Feb 2006 JP
2009512505 Mar 2009 JP
2013527784 Jul 2013 JP
2013536044 Sep 2013 JP
2014522261 Sep 2014 JP
2014523261 Sep 2014 JP
1983003191 Sep 1983 WO
1993001863 Feb 1993 WO
9612383 Apr 1996 WO
2000002623 Jan 2000 WO
2002036003 Nov 2001 WO
2002038031 May 2002 WO
2002049500 Jun 2002 WO
2003028521 Apr 2003 WO
2003043690 May 2003 WO
2003103484 Dec 2003 WO
2004021885 Mar 2004 WO
2004103455 Dec 2004 WO
2005032656 Apr 2005 WO
2005105202 Nov 2005 WO
2006091636 Aug 2006 WO
2007050657 May 2007 WO
2007064936 Jun 2007 WO
2007127926 Nov 2007 WO
2007130170 Nov 2007 WO
2008004204 Jan 2008 WO
2008049199 May 2008 WO
2009002072 Dec 2008 WO
2009002579 Dec 2008 WO
2009010870 Jan 2009 WO
2009130515 Oct 2009 WO
2009146427 Dec 2009 WO
2010013170 Feb 2010 WO
2010044989 Apr 2010 WO
2010051392 May 2010 WO
2010057046 May 2010 WO
2010124139 Oct 2010 WO
2010138915 Dec 2010 WO
2011011327 Jan 2011 WO
2011066477 Jun 2011 WO
2011066478 Jun 2011 WO
2011112843 Sep 2011 WO
2011119251 Sep 2011 WO
2011159545 Dec 2011 WO
2012027252 Mar 2012 WO
2012027791 Mar 2012 WO
2012155183 Nov 2012 WO
2012155184 Nov 2012 WO
2012155185 Nov 2012 WO
2012155187 Nov 2012 WO
2012155188 Nov 2012 WO
2012155189 Nov 2012 WO
2012155190 Nov 2012 WO
2013063111 May 2013 WO
2013075171 May 2013 WO
2014071445 May 2014 WO
2014071446 May 2014 WO
2014143577 Sep 2014 WO
2015070281 May 2015 WO
2015074121 May 2015 WO
2015109239 Jul 2015 WO
2015143509 Oct 2015 WO
2015168735 Nov 2015 WO
2016011512 Jan 2016 WO
2016059556 Apr 2016 WO
2016077882 May 2016 WO
2016090420 Jun 2016 WO
2016090436 Jun 2016 WO
2016115596 Jul 2016 WO
2016161484 Oct 2016 WO
2016191807 Dec 2016 WO
2016191808 Dec 2016 WO
2016191815 Dec 2016 WO
2017173493 Oct 2017 WO
2017219096 Dec 2017 WO
2019178634 Sep 2019 WO
Non-Patent Literature Citations (201)
Entry
Extended European Search Report for European Application No. 16739680.3, Search completed Jun. 1, 2018, dated Jun. 12, 2018, 9 Pgs.
French et al., “Information transmission at 500 bits/s by action potentials in a mechanosensory neuron of the cockroach”, Neuroscience Letters, vol. 243, No. 1-3, Feb. 1, 1998, pp. 113-116.
Herreras, “Local Field Potentials: Myths and Misunderstandings”, Frontiers in Neural Circuits, Dec. 15, 2016, 16 pgs.
Al-Ani et al., “Automatic removal of high-amplitude stimulus artefact from neuronal signal recorded in the subthalamic nucleus”, Journal of Neuroscience Methods, vol. 198, Issue 1, 2011, pp. 135-146.
Extended European Search Report for European Application No. 15768956.3, Search completed Oct. 3, 2017, dated Oct. 10, 2017, 8 Pgs.
Borg et al., “Conduction velocity and refractory period of single motor nerve fibres in antecedent poliomyelitis”, Journal of Neurology, Neurosurgery, and Psychiatry, vol. 50, 1987, 443-446.
Brown et al., “Impact of Deep Brain Stimulation on Upper Limb Askinesia in Parkingson's Disease”, Annals of Neurology, 45, No. 4, 1999, pp. 473-488.
Budagavi et al., “Modelling of compound nerve action potentials health and disease”, Engineering in Medicine and Biology Society, 1992 14th Annual International Conference of the IEEE. vol. 6. IEEE, 1992. pp. 2600-2601.
Coquery et al., “Backward and forward masking in the perception of cutaneous stimuli”, Perception & Psychophysics, 1973, vol. 13.No. 2, pp. 161-163.
Dawson, G. D., “The relative excitability and conduction velocity of sensory and motor nerve fibres in man”, Journal of Physiology, 1956, vol. 131(2), pp. 436-451.
Devergnas et al. A., “Cortical potentials evoked by deep brain stimulation in the subthalamic area”, Front Syst Neurosci. 2011; 5: 30. May 13, 2011. doi:10.3389/fnsys.2011.00030.
Dijkstra, E. A., “Ultrasonic Distance Detection for a Closed-Loop Spinal Cord Stimulation System”, Proceedings—19th International Conference—IEEE/EMBS Oct. 30-Nov. 2, 1997, Chicago, IL, 4 pgs.
Dillier, N. et al., “Measurement of the electrically evoked compound action potential via a neural response telemetry system”, Ann. Otol. Rhinol. Laryngol, vol. 111, No. 5, May 2002, pp. 407-414.
Doiron et al., “Persistent Na+ Current Modifies Burst Discharge By Regulating Conditional Backpropagation of Dendritic Spikes”, Journal of Neurophysiology 89, No. 1 (Jan. 1, 2003): 324-337, doi:10.1152/jn.00729.2002.
England et al., “Increased Numbers of Sodium Channels Form Along Demyelinated Axons”, Brain Research 548, No. 1-2 (May 10, 1991): 334-337.
Fagius, J. et al., “Sympathetic Reflex Latencies and Conduction Velocities in Normal Man”, Journal of Neurological Sciences, 1980. vol. 47, pp. 433-448.
Falowski et al., “Spinal Cord Stimulation: an update”, Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics 5, No. 1, Jan. 2008, pp. 86-99.
Franke et al., Felix, “An Online Spike Detection and Spike Classification Algorithm Capable of Instantaneous Resolution of Overlapping Spikes”, Journal of Computational Neuroscience, 2010, vol. 29, No. 1-2, pp. 127-148.
Fuentes et al., “Spinal Cord Stimulation Restores Locomotion in Animal Models of Parkinson's Disease”, Science, vol. 323, No. 5921, Mar. 20, 2009, pp. 1578-1582.
George et al., “Vagus nerve stimulation: a new tool for brain research and therapy”, Biological Psychiatry 47, No. 4, Feb. 15, 2000, pp. 287-295.
Goodall, E. V., “Modeling Study of Activation and Propagation delays During Stimulation of Peripheral Nerve Fibres with a Tripolar Cuff Electrode”, IEEE Transactions on Rehabilitation Engineering, vol. 3, No. 3, Sep. 1995, pp. 272-282.
Gorman et al., “ECAP Mapping of the Spinal Cord: Influence of Electrode Position on Aβ Recruitment”, (2012), In 16th Annual Meeting. Presented at the North American Neuromodulation Society, Las Vegas, NV.
Gorman et al., “Neural Recordings For Feedback Control Of Spinal Cord Stimulation: Reduction Of Paresthesia Variability”, 2013, In International Neuromodulation Society 11th World Congress. Presented at the International Neuromodulation Society 11th World Congress, Berlin, Germany.
Hallstrom et al, “Distribution of lumbar spinal evoked potentials and their correlation with stimulation-induced paresthesiae”, (1991), Electroencephalography and clinical neurophysiology 80:126-139.
Harper, A. A. et al., “Conduction Velocity is Related to Morphological Cell Type in Rat Dorsal Root Ganglion Neurones”, J. Physiol, (1985), 359, pp. 31-46.
Holsheimer et al., “Optimum Electrode Geometry for Spinal Cord Stimulation: the Narrow Bipole and Tripole”, Medical and Biological Engineering and Computing, 35, No. 5, 1997, pp. 493-497.
Huff, Terry B. et al., “Real-Time CARS Imaging Reveals a Calpain-Dependent Pathway for Paranodal Myelin Retraction during High-Frequency Stimulation”, PLoS ONE vol. 6, issue 3 (Mar. 3, 2011): e17176, 11 pgs.
Ouyang et al., “Compression Induces Acute Demyelination and Potassium Channel Exposure in Spinal Cord”, Journal of Neurotrauma 27, No. 6, Jun. 2010, 1109-1120, doi:10.1089/neu.2010.1271.
Kent et al., “Instrumentation to Record Evoked Potentials for Closed-Loop Control of Deep Brain Stimulation”, Conf. Proc. IEEE Eng. Med Biol. Sol, Aug. 2012, 10 pgs.
Kent et al., AR, “Recording evoked potentials during deep brain stimulation: development and validation of instrumentation to suppress the stimulus artefact”, J Neural Eng. Jun. 2012; 9 (3):036004, Apr. 18, 2012. doi: 10.1088/1741-2560/9/3/036004.
Kim et al., “A Wavelet-Based Method for Action Potential Detection From Extracellular Neural Signal Recording Wth Low Signal-to-Noise Ratio”, IEEE Transactions On Biomedical Engineering, vol. 50. No. 8, Aug. 2003.
Kim et al., “Cell Type-specific Changes of the Membrane Properties of Peripherally-axotomized Dorsal Root Ganglion Neurons in a Rat Model of Neuropathic Pain”, Neuroscience 86, No. 1 (May 21, 1998): 301-309, doi:10.1016/S0306-4522(98)00022-0.
Krames et al., “Neuromodulation”, 1st Edition, Academic Press, 2009, p. 540-541.
Krarup, Christian, “Compound sensory action potential in normal and pathological human nerves”, Muscle & nerve, vol. 29, No. 4 (2004), pp. 465-483.
Krishnan et al., “Excitability Differences in Lower-Limb Motor Axons During and After Ischemia”, Muscle & nerve, vol. 31, No. 2 (2005), pp. 205-213.
Kumar et al., “Deep Brain Stimulation for Intractable Pain: a 15-year Experience”, Neurosurgery, Issue 40, No. 4, Apr. 1997, pp. 736-747.
Kumar et al., “Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease”, by the American Academy of Neurology, 51, No. 3, Sep. 1, 1998, pp. 850-855.
Kumar et al., “Globus Pallidus Deep Brain Stimulation for Generalized Dystonia: Clinical and PET Investigation”, Neurology, 53, No. 4, 1999, pp. 871-874.
Laird et al., “A Model of Evoked Potentials in Spinal Cord Stimulation”, IEEE Engineering in Medicine & Biology Society, 35th Annual Conference. Osaka, Japan: Jul. 3-7, 2013, pp. 6555-6558.
Lempka, Scott, “The Electrode-Tissue Interface During Recording and Stimulation In The Central Nervous System”, published on May, 2010.
Levy et al., “Incidence and Avoidance of Neurologic Complications with Paddle Type Spinal Cord Stimulation Leads”, Neuromodulation 14(15), Sep. 2011, pp. 412-422.
Li et al., S, “Resonant antidromic cortical circuit activation as a consequence of high-frequency subthalamic deep-brain stimulation”, J Neurophysiol. Dec. 2007; 98(6): 3525-37. First published Oct. 10, 2007. doi:10.1152/jn.00808.2007.
Ma et al., “Similar Electrophysiological Changes in Axotomized and Neighboring Intact Dorsal Root Ganglion Neurons”, Journal of Neurophysiology 89, No. 3 (Mar. 1, 2003): 1588-1602, doi:10.1152/jn.00855.2002.
Macefield, “Spontaneous and Evoked Ectopic Discharges Recorded from Single Human Axons”, Muscle & Nerve 21, No. 4, Apr. 1998, pp. 461-468.
Mahnam, A et al., “Measurement of the current-distance relationship using a novel refractory interaction technique”, J. Neural Eng. 6 (2009), pp. 036005 (published May 20, 2009) Abstract, Sec. 2.2 & Figure 2b, 036005.
Markandey, Vishal, “ECG Implementation on the TMS320C5515 DSP Medical Development Kit (MDK)”, Texas Instruments Application Report Jun. 2010, 35 pgs.
Massachusetts Institute of Techn, “The Compound Action Potential of the Frog Sciatic Nerve”, Quantitative Physiology: Cells and Tissues. Fall, 1999, Retrieved from http://umech.mit.edu/freeman/6.021J/2001/lab.pdf on May 22, 2012.
Matzner et al., “Na+ Conductance and the Threshold for Repetitive Neuronal Firing”, Brain Research 597, No. 1 (Nov. 27, 1992): 92-98, doi:10.1016/0006-8993(92)91509-D.
McGill, Kevin et al., “On the Nature and Elimination of Stimulus Artifact in Nerve Signals Evoked and Recorded Using Surface Electrodes”, IEEE Transactions On Biomedical Engineering, vol. BME-29, No. 2, Feb. 1982, pp. 129-137.
Melzack et al., “Pain mechanisms: a new theory”, Science, New York, New York, vol. 150, No. 3699, Nov. 19, 1965, pp. 971-979.
Miles et al., “An Electrode for Prolonged Stimulation of the Brain”, Proc. 8th Meeting World Soc. Stereotactic and Functional Neurosurgery, Part III, Zurich, 1981, Appl. Neurophysiol, 45, 1982, pp. 449-445 1982.
Misawa et al., “Neuropathic Pain Is Associated with Increased Nodal Persistent Na(+) Currents in Human Diabetic Neuropathy”, Journal of the Peripheral Nervous System: JPNS, 14, No. 4 (Dec. 2009): 279-284.
Nordin et al., “Ectopic Sensory Discharges and Paresthesiae in Patients with Disorders of Peripheral Nerves, Dorsal Roots and Dorsal Columns”, Pain 20, No. 3 (Nov. 1984): 231-245, doi: 10.1016/0304-3959(84)90013-7.
Oakley et al., “Spinal Cord Stimulation: Mechanisms of Action”, Spine 27, No. 22, Nov. 15, 2002, pp. 2574-2583.
Oakley et al., “Transverse Tripolar Spinal Cord Stimulation: Results of an International Multicenter Study”, Neuromodulation, vol. 9, No. 3, 2006, pp. 192-203.
Obradovic et al., “Effect of pressure on the spinal cord during spinal cord stimulation in an animal model”, Poster, 18th Annual Meeting of the North American Neuromodulation Society, Dec. 11-14, 2014, Las Vegas.
Oh et al., “Long-term hardware-related complications of deep brain stimulation”, Neurosurgery, vol. 50, No. 6, Jun. 2002, pp. 1268-1274, discussion pp. 1274-1276.
Opsommer, E. et al., “Determination of Nerve Conduction Velocity of C-fibres in Humans from Thermal Thresholds to Contact Heat (Thermode) and from Evoked Brain Potentials to Radiant Heat (CO2 Laser)”, Neurophysiologie Clinique 1999, vol. 29, pp. 411-422.
Orstavik, Kristin et al., “Pathological C-fibres in patients with a chronic painful condition”, Brain (2003), 126, 567-578.
Parker et al., “Closing the Loop in Neuromodulation Therapies: Spinal Cord Evoked Compound Action Potentials During Stimulation for Pain Management (230)”, 2011, In 15th Annual Meeting, North American Neuromodulation Society (p. 48). Presented at the North American Neuromodulation Society, Las Vegas.
Parker et al., “Compound action potentials recorded in the human spinal cord during neurostimulation for pain relief”, Pain, 2012, vol. 153, pp. 593-601.
European Search Report for European Application 12785619.3 Search Completed Oct. 13, 2014, dated Oct. 23, 2014, 7 pgs.
European Search Report for European Application 12785669.8 Search Completed Sep. 22, 2014, dated Sep. 29, 2014, 5 pgs.
Extended European Search Report for EP Application 12785483.4 completed Sep. 16, 2014, 7 pgs.
Extended European Search Report for European Application No. 11820923.8, report completed Dec. 9, 2013, report dated Dec. 17, 2013, 6 pgs.
Extended European Search Report for European Application No. 13852669.4, Search completed Jun. 8, 2016, dated Jun. 22, 2016, 9 pgs.
Extended European Search Report for European Application No. 14861553.7, Search completed Jun. 8, 2017, dated Jun. 19, 2017, 8 pgs.
Extended European Search Report for European Application No. 14863597.2, Search completed Jun. 6, 2017, dated Jun. 13, 2017, 9 pgs.
Extended European Search Report for European Application No. 13853514.1, Search completed Jun. 8, 2016, dated Jun. 15, 2016, 7 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2012/001441, Report dated May 27, 2014, 10 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2011/001127, date completed Nov. 11, 2011, dated Nov. 15, 2011, 13 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2012/001441, International Filing Date Nov. 23, 2012, Search Completed Feb. 26, 2013, dated Feb. 26, 2013, 14 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2014/001049, Search completed Feb. 10, 2015, dated Feb. 10, 2015, 8 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2014/050369, Search completed Feb. 20, 2015, dated Feb. 20, 2015, 14 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2015/050135, Search completed Jun. 30, 2015, dated Jun. 30, 2015, 26 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2015/050422, Search completed Oct. 14, 2015, dated Oct. 14, 2015, 17 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2015/050724, Search completed May 9, 2016, dated May 9, 2016, 8 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2015/050753, Search completed Feb. 10, 2016, dated Feb. 10, 2016, 10 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2015/050787, Search completed Mar. 16, 2016, dated Mar. 16, 2016, 10 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2016/050019, Search completed May 4, 2016, dated May 4, 2016, 16 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2015/050215, Search completed Jul. 30, 2015, dated Jul. 30, 2015, 8 pgs.
International Search Report for Australian Application 2011901829 Search Completed Feb. 6, 2012, dated Feb. 7, 2012, 3 pgs.
International Search Report for International Application No. PCT/AU2012/000511, International Filing Date May 11, 2012, Search Completed May 17, 2012, dated May 18, 2012, 4 pgs.
International Search Report for International Application No. PCT/AU2012/000512, International Filing Date May 11, 2012, Search Completed Jul. 10, 2012, dated Jul. 11, 2012, 4 pgs.
International Search Report for International Application No. PCT/AU2012/000513, International Filing Date May 11, 2012, Search Completed May 29, 2012, dated May 30, 2012, 5 pgs.
International Search Report for International Application No. PCT/AU2012/000515, International Filing Date May 11, 2012, Search Completed May 21, 2012, dated Jun. 4, 2012, 5 pgs.
International Search Report for International Application No. PCT/AU2012/000516, International Filing Date May 11, 2012, Search Completed Jul. 11, 2012, dated Jul. 12, 2012, 8 pgs.
International Search Report for International Application No. PCT/AU2012/000517, International Filing Date May 11, 2012, Search Completed Jun. 4, 2012, dated Jun. 6, 2012, 3 pgs.
International Search Report for International Application No. PCT/AU2012/000518, International Filing Date May 11, 2012, Search Completed Jun. 8, 2012, dated Jun. 12, 2012, 4 pgs.
Medtronic, Spinal Cord Stimulation, RestoreSensor Neurostimulator, Features and Specification: Specification, Printed Jun. 16, 2014, 2 pgs.
Medtronic, Spinal Cord Stimulation, RestoreSensor Neurostimulator, Features and Specification: Summary Printed Jun. 16, 2014, 1 pg.
Written Opinion for International Application No. PCT/AU2012/000511, International Filing Date May 11, 2012, Search Completed May 17, 2012, dated May 18, 2012, 5 pgs.
Written Opinion for International Application No. PCT/AU2012/000512, International Filing Date May 11, 2012, Search Completed Jul. 10, 2012, dated Jul. 11, 2012, 7 pgs.
Written Opinion for International Application No. PCT/AU2012/000513, International Filing Date May 11, 2012, Search Completed May 29, 2012, dated May 30, 2012, 10 pgs.
Written Opinion for International Application No. PCT/AU2012/000515, International Filing Date May 11, 2012, Search Completed May 21, 2012, dated Jun. 4, 2012, 4 pgs.
Written Opinion for International Application No. PCT/AU2012/000516, International Filing Date May 11, 2012, Search Completed Jul. 11, 2012, dated Jul. 12, 2012, 8 pgs.
Written Opinion for International Application No. PCT/AU2012/000517, International Filing Date May 11, 2012, Search Completed Jun. 4, 2012, dated Jun. 6, 2012, 5 pgs.
Written Opinion for International Application No. PCT/AU2012/000518, International Filing Date May 11, 2012, Search Completed Jun. 8, 2012, dated Jun. 12, 2012, 10 pgs.
Medtronic, RestoreSensor Neurostimulator, Retrieved from: http://web.archive.org/web/20150328092923/http://professional.medtronic.com:80/pt/neuro/scs/prod/restore-sensor/features-specifications/index.htm, Capture Date Jul. 9, 2012, Printed on May 11, 2017.
“Advanced Pain Therapy using Neurostimulation for Chronic Pain”, Medtronic RestoreSensor clinical trial paper, Clinical summary, Nov. 2011, pp. 32.
“Battelle Neurotechnology—Moving Beyond The Limits in Neurotechnology”, Battelle, www.battelle.org, May 2014, pp. 1-2.
“Haptic technology”, Wikipedia, Retrieved from: http://en.wikipedia.org/wiki/Haptic_technology, Last modified on Sep. 15, 2014, Printed on Sep. 15, 2014, 5 pgs.
“Implants for surgery, Cardiac pacemakers”, IS-1 standard ISO 5841-3-2000, Oct. 15, 2000.
International Search Report & Written Opinion for International Application No. PCT/AU2013/001280, Search Completed Jan. 16, 2014, dated Jan. 16, 2014, 8 Pgs.
International Search Report & Written Opinion for International Application PCT/AU2013/001279, Search Completed Jan. 9, 2014, dated Jan. 9, 2014, 9 pgs.
“Neural Bypass Technology Enables Movement in Paralyzed Patient”, Posted on Jul. 29, 2014, 6 a.m. in Brain chips/computer interface, pp. 1-2.
“Spinal Cord Stimulation, About Spinal Cord Stimulation”, Medtronic, Retrieved from: http://professional.medtronic.com/pt/neuro/scs/edu/about/index.htm, Printed on Jun. 16, 2014, 2 pgs.
“Wide bandwidth BioAmplifier”, http://www.psylab.com/html/default_bioamp.htm, Printed Jan. 30, 2014, 1-3 pages.
Andreassen, S. et al., “Muscle Fibre Conduction Velocity in Motor Units of the Human Anterior Tibial Muscle: a New Size Principle Parameter”, J. Physiol, (1987), 391, pp. 561-571.
Andy, “Parafascicular-Center Median Nuclei Stimulation for Intractable Pain and Dyskinesia (Painful-Dyskinesia)”, Stereotactic and Functional Neurosurgery, Appl. Neurophysiol., 43, No. 3-5, 1980, pp. 133-144.
Balzer et al., “Localization of cervical and cervicomedullary stimulation leads for pain treatment using median nerve somatosensay evoked potential collision testing”, Journal of Neurosurgery, Jan. 2011, vol. 114, No. 1: pp. 200-205.
Blum, A. R., “An Electronic System for Extracelluar Neural Stimulation and Recording”, Dissertation, Georgia Institute of Technology, Aug. 2007, Retrieved from http://smartech.gatech.edu/handle/1853/16192 on Jan. 30, 2012.
European Search Report for European Application No. 15861444.6, Search completed Jul. 13, 2018, dated Jul. 23, 2018, 8 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2017/050296, Search completed Jul. 28, 2017, dated Jul. 28, 2017, 10 pgs.
He et al., “Perception threshold and electrode position for spinal cord stimulation”, Pain, 59 (1994) 55-63 pages.
Holsheimer et al., “Significance of the Spinal Cord Position in Spinal Cord Stimulation”, Acta Neurochir (1995) [Suppl] 64: 119-124 pages.
Holsheimer et al., “Spinal Geometry and Paresthesia Coverage in Spinal Cord Stimulation”, (1998 paper) 8 pages.
Olin et al., “Postural Changes in Spinal Cord Stimulation Perceptual Thresholds”, Neuromodulation, vol. 1, No. 4, 1998, pp. 171-175.
Rattay, “Analysis of Models for External Stimulation of Axons”, IEEE Transactions on Biomedical Engineering, vol. BME-33, No. 10, Oct. 1986, pp. 974-977.
Ross et al., “Improving Patient Experience with Spinal Cord Stimulation: Implications of Position-Related Changes in Neurostimulation”, Neuromodulation 2011; e-pub ahead of print. DOI: 10.1111/j.1525-1403.2011.00407.x 6 pages.
Struijk, “The Extracellular Potential of a Myelinated Nerve Fiber in an Unbounded Medium and in Nerve Cuff Models”, Biophysical Journal, vol. 72, Jun. 1997, pp. 2457-2469.
International Preliminary Report on Patentability for International Application No. PCT/AU2011/001127, Report dated Mar. 5, 2013, 9 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2012/000511, Report dated Nov. 19, 2013, 6 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2012/000512, Report dated Nov. 19, 2013, 8 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2012/000513, Report dated Nov. 19, 2013, 11 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2012/000515, Report dated Nov. 19, 2013, 5 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2012/000516, Report dated Nov. 19, 2013, 9 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2012/000517, Report dated Nov. 19, 2013, 6 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2012/000518, Report dated Nov. 19, 2013, 11 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2013/001279, Report dated May 12, 2015, 6 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2013/001280, Report dated May 12, 2015, 6 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2014/001049, Report dated May 17, 2016, 5 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2014/050369, Report dated May 24, 2016, 8 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2015/050135, Report dated Oct. 4, 2016, 13 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2015/050215, Report dated Nov. 8, 2016, 4 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2015/050422, Report dated Jan. 31, 2017, 8 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2015/050724, Report dated May 23, 2017, 5 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2015/050787, Report dated Jun. 13, 2017, 6 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2016/050019, Report dated Jul. 25, 2017, 9 pgs.
International Preliminary Report on Patentability for International Application No. PCT/AU2016/050263, Report dated Oct. 10, 2017, 9 pgs.
International Type Search Report for International Application No. AU 2015902393, Search completed May 16, 2016, dated May 16, 2016, 8 Pgs.
Parker et al., “Electrically Evoked Compound Action Potentials Recorded From the Sheep Spinal Cord”, Neuromodulation, vol. 16, 2013, pp. 295-303.
Penar et al., “Cortical Evoked Potentials Used for Placement of a Laminotomy Lead Array: A Case Report”, Neuromodulation: Technology at the Neural Interface, accessed Apr. 19, 2011, doi:10.1111/j.1525-1403.2011.00352.x.
Richter et al., “EMG and SSEP Monitoring During Cervical Spinal Cord Stimulation”, Journal of Neurosurgical Review 2011, Southern Academic Press, 1(S1), 2011, pp. 61-63.
Ridder et al., “Burst Spinal Cord Stimulation for Limb and Back Pain”, World Neurosurgery, 2013, 9 pgs.
Ridder et al., “Burst Spinal Cord Stimulation toward Paresthesia-Free Pain Suppression”, May 2010, vol. 66, pp. 986-990.
Roy, S. H. et al., “Effects of Electrode Location on Myoelectric Conduction Velocity and Median Frequency Estimates”, J. Appl. Physiol. 61 (4), 1986, pp. 1510-1517.
Schmidt et al., “Gating of tactile input from the hand”, Exp Brain Res, 1990, 79, pp. 97-102.
Siegfried et al., “Bilateral Chronic Electrostimulation of Ventroposterolateral Pallidum: A New Therapeutic Approach for Alleviating all Parkinsonian Symptoms”, Neurosurgery, 35, No. 6, Dec. 1994, pp. 1126-1130.
Siegfried et al., “Intracerebral Electrode Implantation System”, Journal of Neurosurgery, vol. 59, No. 2, Aug. 1983, pp. 356-3591.
Srinivasan, S, “Electrode/Electrolyte Interfaces: Structure and Kinetics of Charge Transfer”, Fuel Cells, 2006, Chapter 2, 67 Pages.
Struijk et al, “Paresthesia Thresholds in Spinal Cord Stimulation: A Comparison of Theoretical Results with Clinical Data”, IEEE Transactions on Rehabilitation Engineering, vol. 1, No. 2, Jun. 1993, pp. 101-108.
Sufka et al., “Gate Control Theory Reconsidered”, Brain and Mind, 3, No. 2, 2002, pp. 277-290.
Tamura et al., “Increased Nodal Persistent Na+ Currents in Human Neuropathy and Motor Neuron Disease Estimated by Latent Addition”, Clinical Neurophysiology 117, No. 11 (Nov. 2006): 2451-2458, doi:10.1016/j.clinph.2006.07.309.
Tasker, “Deep Brain Stimulation is Preferable to Thalamotomy for Tremor Suppression”, Surgical Neurology, 49, No. 2, 1998, pp. 145-153.
Taylor et al., “Spinal Cord Stimulation for Chronic Back and Leg Pain and Failed Back Surgery Syndrome: A Systematic Review and Analysis of Prognostic Factors”, SPINE, vol. 30, No. 1, 2004, pp. 152-160.
Texas Instruments, “Precision, Low Power Instrumentation Amplifiers”, Texas Instruments SBOS051B Oct. 1995, Revised Feb. 2005, 20 pgs.
Tomas et al., “Dorsal Root Entry Zone (DREZ) Localization Using Direct Spinal Cord Stimulation Can Improve Results of the DREZ Thermocoagulation Procedure for Intractable Pain Relief”, Pain, 2005, vol. 116, pp. 159-163.
Tscherter et al., “Spatiotemporal Characterization of Rhythmic Activity in Rat Spinal Cord Slice Cultures”, European Journal of Neuroscience 14, No. 2 (2001), pp. 179-190.
Van Den Berg et al., “Nerve fiber size-related block of action currents by phenytoin in mammalian nerve”, Epilepsia, Nov. 1994, 35(6), pp. 1279-1288.
Villavicencio, Alan T., “Laminectomy versus Percutaneous Electrode Placement for Spinal Cord Stimulation,” Neurosurgery, vol. 46 (2), Feb. 2000, pp. 399-405.
Vleggeert et al., Lankamp, “Electrophysiology and morphometry of the Aalpha- and Abeta-fiber populations in the normal and regenerating rat sciatic nerve”, Experimental Neurology, vol. 187, No. 2, Jun. 1, 2004, Available online Apr. 2, 2004, pp. 337-349.
Woessner, “Blocking Out the Pain, Electric Nerve Block Treatments for Sciatic Neuritis”, Retrieved from: http://www.practicalpainmanagement.com/pain/spine/radiculopathy/blocking-out-pain, Last updated Jan. 10, 2012.
Wolter et al., “Effects of sub-perception threshold spinal cord stimulation in neuropathic pain: A randomized controlled double-blind crossover study”, European Federation of International Association for the Study of Pain Chapters, 2012, pp. 648-655.
Wu et al., “Changes in Aβ Non-nociceptive Primary Sensory Neurons in a Rat Model of Osteoarthritis Pain”, Molecular Pain 6, No. 1 (Jul. 1, 2010): 37, doi: 10.1186/1744-8069-6-37.
Xie et al., “Functional Changes in Dorsal Root Ganglion Cells after Chronic Nerve Constriction in the Rat”, Journal of Neurophysiology 73, No. 5 (May 1, 1995): 1811-1820.
Xie et al., “Sinusoidal Time-Frequency Wavelet Family and its Application in Electrograstrographic Signal Analysis”, Proceedings of the 20th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 20, No. 3, Oct. 29, 1998, pp. 1450-1453.
Yearwood, T. L., “Pulse Width Programming in Spinal Cord Stimulation: a Clinical Study”, Pain Physician. 2010. vol. 13, pp. 321-335.
Yingling et al., “Use of Antidromic Evoked Potentials in Placement of Dorsal Cord Disc Electrodes”, Applied Neurophysiology, 1986, vol. 49, pp. 36-41.
Yuan, S. et al., “Recording monophasic action potentials using a platinum-electrode ablation catheter”, Europace. Oct. 2000; 2(4):312-319.
International Preliminary Report on Patentability for International Application No. PCT/AU2015/050753, Report dated Jun. 13, 2017, 7 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2016/050263, Search completed Nov. 16, 2016, dated Nov. 16, 2016, 8 Pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2016/050430, Search completed Aug. 16, 2016, dated Aug. 16, 2016, 10 Pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2016/050431, Search completed Aug. 16, 2016, dated Aug. 16, 2016, 11 Pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2016/050439, Search completed Jul. 15, 2016, dated Jul. 15, 2016, 8 Pgs.
Alam et al., “Evaluation of optimal electrode configurations for epidural spinal cord stimulation in cervical spinal cord injured rats”, Journal of Neuroscience Methods, Mar. 2015, 28 pgs.
Fisher, “F-Waves—Physiology and Clinical Uses”, The Scientific World Journal, (2007) 7, pp. 144-160.
Gad et al., “Development of a multi-electrode array for spinal cord epidural stimulation to facilitate stepping and standing after a complete spinal cord injury in adult rats”, Journal of NeuroEngineering and Rehabilitation 2013, 10:2, 18 pgs.
Sayenko et al., “Neuromodulation of evoked muscle potentials induced by epidural spinal-cord stimulation in paralyzed individuals”, Journal of Neurophysiology, vol. 111, No. 5, 2014, pp. 1088-1099, First published Dec. 11, 2013.
Struijk et al., “Excitation of Dorsal Root Fibers in Spinal Cord Stimulation: a Theoretical Study”, IEEE Transactions on Biomedical Engineering, Jul. 1993, vol. 40, No. 7, pp. 632-639.
Yamada et al., “Extraction and Analysis of the Single Motor Unit F-Wave of the Median Nerve”, EMG Methods for Evaluating Muscle and Nerve Function, InTech, 2012, 15 pgs.
Extended European Search Report for European Application No. 16802237.4, Search completed Dec. 11, 2018, dated Dec. 19, 2018, 9 Pgs.
Extended European Search Report for European Application No. 16802238.2, Search completed Oct. 17, 2018, dated Oct. 24, 2018, 8 Pgs.
International Preliminary Report for International Application No. PCT/AU2017/050296, dated Oct. 9, 2018, 7 Pgs.
International Preliminary Report for International Application No. PCT/AU2017/050647, dated Dec. 25, 2018, 8 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2017/050647, Search completed Sep. 29, 2017, dated Sep. 29, 2017, 13 Pgs.
Partial European Search Report for European Application No. 16775966.1, Search completed Oct. 26, 2018, dated Nov. 6, 2018, 11 Pgs.
Bahmer et al., “Application of triphasic pulses with adjustable phase amplitude ratio (PAR) for cochlear ECAP recording: I. Amplitude growth functions”, Journal of Neuroscience Methods, Clinical Neuroscience, 2012, vol. 205, pp. 202-211.
Bahmer et al., “Effects of electrical pulse polarity shape on intra cochlear neural responses in humans: Triphasic pulses with cathodic second phase”, Hearing Research, 2013, vol. 306, pp. 123-130.
Gnadt et al., “Spectral Cancellation of Microstimulation Artifact for Simultaneous Neural Recording In Situ”, IEEE Transactions on Biomedical Engineering, Oct. 2003, Date of Publication: Sep. 23, 2003, vol. 50, No. 10, pp. 1129-1135, DOI: 10.1109/TBME.2003.816077.
Jeffrey et al., “A reliable method for intracranial electrode implantation and chronic electrical stimulation in the mouse brain”, BMC Neuroscience. Biomed Central. London. GB. vol. 14, No. 1, Aug. 6, 2013, p. 82.
Tronnier et al., “Magnetic Resonance Imaging with Implanted Neurostimulators: An In Vitro and In Vivo Study”, Jan. 1999, Neurosurgery, vol. 44(1), pp. 118-125.
Extended European Search Report for European Application No. 17778477.4, report completed Nov. 12, 2019, dated Nov. 20, 2019, 7 pgs.
Extended European Search Report for European Application No. 17814341.8, report completed Dec. 12, 2019, report dated Jan. 2, 2020, 8 pgs.
Japanese Office Action for Application No. 2017-546830, dated Feb. 20, 2020, 5 pages with English translation.
Japanese Office Action for Application No. 2017-553090, dated Mar. 16, 2020, 12 pages with English translation.
Japanese Office Action for Application No. 2018-513699, dated Jun. 8, 2020, 7 pages with English translation.
Office Action for Chinese Patent Application No. 201680020725.4, dated Mar. 16, 2020, 8 pgs.
Kopelman et al., “Attempted Reversible Sympathetic Ganglion Block by An Implantable Neurostimulator”, Interactive CardioVascular and Thoracic Surgery, Feb. 7, 2012, vol. 14, Issue 5, pp. 605-609.
International Preliminary Report on Patentability for International Application No. PCT/AU2018/050278, dated Sep. 29, 2020, 7 pgs.
International Search Report and Written Opinion for International Application No. PCT/AU2018/050278, Search completed Jun. 18, 2018, dated Jun. 18, 2018, 12 Pgs.
Related Publications (1)
Number Date Country
20180229046 A1 Aug 2018 US